MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma

[1]  C. Croce,et al.  The role of microRNA genes in papillary thyroid carcinoma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[3]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[4]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[5]  J. Fletcher,et al.  Protein kinase C-θ regulates KIT expression and proliferation in gastrointestinal stromal tumors , 2008, Oncogene.

[6]  Roberta Galli,et al.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.

[7]  M. Xing,et al.  BRAF mutation in thyroid cancer. , 2005, Endocrine-related cancer.

[8]  Subbaya Subramanian,et al.  MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.

[9]  H. Rabes,et al.  Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  N. Nikitakis,et al.  High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma , 2007, Molecular Cancer.

[11]  A. Hui,et al.  Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98 , 2010, Cell Death and Disease.

[12]  M. Rahat,et al.  Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-gamma and tumor necrosis factor-alpha in human thyroid carcinoma cells. , 2001, International immunology.

[13]  Dillwyn Williams.  Cancer after nuclear fallout: lessons from the Chernobyl accident , 2002, Nature Reviews Cancer.

[14]  Andrea Sottoriva,et al.  The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.

[15]  R. Malenka,et al.  An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration , 2012, Nature Neuroscience.

[16]  David F. Schneider,et al.  New developments in the diagnosis and treatment of thyroid cancer , 2013, CA: a cancer journal for clinicians.

[17]  M. Menon,et al.  Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications , 2009, Journal of Clinical Pathology.

[18]  M. Xing,et al.  Molecular pathogenesis and mechanisms of thyroid cancer , 2013, Nature Reviews Cancer.

[19]  Sebastian Amigorena,et al.  Deficient Peptide Loading and MHC Class II Endosomal Sorting in a Human Genetic Immunodeficiency Disease: the Chediak-Higashi Syndrome , 1998, The Journal of cell biology.

[20]  Nan Li,et al.  MicroRNA-148/152 Impair Innate Response and Antigen Presentation of TLR-Triggered Dendritic Cells by Targeting CaMKIIα , 2010, The Journal of Immunology.

[21]  P. Pandolfi,et al.  The multilayered complexity of ceRNA crosstalk and competition , 2014, Nature.

[22]  P. A. Biro,et al.  HLA‐DMB expression by thyrocytes: indication of the antigen‐processing and possible presenting capability of thyroid cells , 1999, Clinical and experimental immunology.

[23]  M. Papotti,et al.  Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis , 2004, British Journal of Cancer.

[24]  C. Tomlinson,et al.  RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response. , 2005, Endocrine-related cancer.

[25]  S. Mishra,et al.  Carcinoma in Graves' disease. , 1995, The Journal of the Association of Physicians of India.

[26]  Stefan L Ameres,et al.  Diversifying microRNA sequence and function , 2013, Nature Reviews Molecular Cell Biology.

[27]  Edwin Wang,et al.  Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. , 2013, Cell reports.

[28]  Kevin P. Banks,et al.  Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescents. , 2002, The Journal of clinical endocrinology and metabolism.

[29]  L. Lim,et al.  A microRNA component of the p53 tumour suppressor network , 2007, Nature.

[30]  M. Schott,et al.  Immunoglobulin G expression and its colocalization with complement proteins in papillary thyroid cancer , 2012 .

[31]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[32]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[33]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[34]  M. Santoro,et al.  RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture. , 2006, European journal of endocrinology.

[35]  Yaou Zhang,et al.  Expression of Versican 3′-Untranslated Region Modulates Endogenous MicroRNA Functions , 2010, PloS one.

[36]  N. Lemoine,et al.  High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. , 1989, Oncogene.

[37]  M. Lovett,et al.  Identification of the homologous beige and Chediak–Higashi syndrome genes , 1996, Nature.

[38]  G. Ruvkun,et al.  Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans , 1993, Cell.

[39]  Burton B. Yang,et al.  The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions , 2012, Journal of Cell Science.

[40]  P. Hou,et al.  Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells. , 2011, Endocrine-related cancer.

[41]  Weining Yang,et al.  Versican 3′‐untranslated region (3′‐UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  F. B. Davis,et al.  Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression. , 1998, Journal of immunology.

[43]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[44]  Kuender D Yang,et al.  Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[45]  M. Gorospe,et al.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. , 2011, Molecular cell.

[46]  M. Rahat,et al.  Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-γ and tumor necrosis factor-α in human thyroid carcinoma cells , 2001 .

[47]  E. Zapanti,et al.  Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease. , 2014, Thyroid : official journal of the American Thyroid Association.

[48]  R. Kloos,et al.  Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)‐like nuclear alterations express molecular markers of PTC , 2004, Histopathology.

[49]  Anjali J. Koppal,et al.  Supplementary data: Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites , 2010 .

[50]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[51]  F. B. Davis,et al.  Potentiation by Thyroid Hormone of Human IFN-γ-Induced HLA-DR Expression , 1998, The Journal of Immunology.

[52]  E. Kimura,et al.  MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer , 2012, Oncogene.

[53]  Aarati R. Ranade,et al.  MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration , 2011, International journal of cancer.

[54]  G. Riggins,et al.  Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis. , 2007, Cancer research.

[55]  M. Fabbri,et al.  MicroRNAs and other non-coding RNAs as targets for anticancer drug development , 2013, Nature Reviews Drug Discovery.

[56]  R. Seethala.  MicroRNA deregulation in human thyroid papillary carcinomas , 2008 .

[57]  V. S. Kazakov,et al.  Thyroid cancer after Chernobyl , 1992, Nature.

[58]  Beth Israel,et al.  Decision letter: Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010 .

[59]  K. Honda,et al.  DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.

[60]  A. El‐Naggar,et al.  IQGAP1 Plays an Important Role in the Invasiveness of Thyroid Cancer , 2010, Clinical Cancer Research.

[61]  Burton B. Yang,et al.  The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions , 2012, Journal of Cell Science.

[62]  P. Leedman,et al.  miRNA-7-5p inhibits melanoma cell migration and invasion. , 2013, Biochemical and biophysical research communications.

[63]  E. Jacobson,et al.  The genetic basis of thyroid autoimmunity. , 2007, Thyroid : official journal of the American Thyroid Association.